Euclidean Technologies Management Portfolio holdings
Top Buys
| 1 |
MarineMax
HZO
|
+$2.71M |
| 2 |
Perdoceo Education
PRDO
|
+$2.58M |
| 3 |
Star Group
SGU
|
+$2.4M |
| 4 |
American Public Education
APEI
|
+$2.33M |
| 5 |
Ingles Markets
IMKTA
|
+$2.31M |
Top Sells
| 1 |
Medifast
MED
|
+$3.6M |
| 2 |
Super Micro Computer
SMCI
|
+$2.93M |
| 3 |
Oshkosh
OSK
|
+$2.65M |
| 4 |
Meritage Homes
MTH
|
+$1.93M |
| 5 |
Anika Therapeutics
ANIK
|
+$1.83M |
Sector Composition
| 1 | Industrials | 38.86% |
| 2 | Consumer Discretionary | 19.96% |
| 3 | Consumer Staples | 13.12% |
| 4 | Technology | 10.18% |
| 5 | Healthcare | 5.47% |
Similar funds
Euclidean Technologies Management's Q2 2021 Portfolio in Review
As of Q2 2021, Euclidean Technologies Management held 104 positions worth $125M, up 9.2% from $115M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Euclidean Technologies Management deployed $7.47M of net new capital in Q2 2021, opening 35 new positions and adding to 23 existing holdings. Its largest new stake was Perdoceo Education: 211,239 shares worth $2.59M.
By sector, the portfolio is most concentrated in Industrials at 39% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was Shoe Station Group, an estimated $1.42M trimmed.
- Euclidean Technologies Management's largest Q2 2021 buy was Perdoceo Education: 211,239 shares worth $2.59M.
- Euclidean Technologies Management added most to MarineMax in Q2 2021, an estimated $2.71M increase.
- Euclidean Technologies Management's biggest Q2 2021 reduction was Shoe Station Group, cutting an estimated $1.42M.
- Euclidean Technologies Management fully exited Medifast in Q2 2021, selling an estimated $3.6M.
- Euclidean Technologies Management's ten largest holdings make up 24% of its $125M portfolio in Q2 2021.
- Euclidean Technologies Management opened 35 new positions and closed 9 in Q2 2021.
- Euclidean Technologies Management's portfolio value rose 9.2% quarter-over-quarter to $125M.
Based on Euclidean Technologies Management's 13F filing for Q2 2021, filed 5 Aug 2021.